Nelson, A. J., Pagidipati, N. J., Kaltenbach, L., Green, J., Lopes, R. D., Al-Khalidi, H., … Granger, C. B. (2024). CHARACTERISTICS OF PERSONS WITH TYPE 2 DIABETES AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE PRESCRIBED SGLT-2I AND/OR GLP-1RA AMONG CARDIOLOGY CLINICS IN THE US: INSIGHTS FROM A LARGE IMPLEMENTATION TRIAL. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 83, pp. 1889–1889).

Nelson, Adam J., Neha J. Pagidipati, Lisa Kaltenbach, Jennifer Green, Renato D. Lopes, Hussein Al-Khalidi, Vanita Aroda, et al. “CHARACTERISTICS OF PERSONS WITH TYPE 2 DIABETES AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE PRESCRIBED SGLT-2I AND/OR GLP-1RA AMONG CARDIOLOGY CLINICS IN THE US: INSIGHTS FROM A LARGE IMPLEMENTATION TRIAL.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 83:1889–1889, 2024.

Nelson AJ, Pagidipati NJ, Kaltenbach L, Green J, Lopes RD, Al-Khalidi H, et al. CHARACTERISTICS OF PERSONS WITH TYPE 2 DIABETES AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE PRESCRIBED SGLT-2I AND/OR GLP-1RA AMONG CARDIOLOGY CLINICS IN THE US: INSIGHTS FROM A LARGE IMPLEMENTATION TRIAL. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2024. p. 1889–1889.

Nelson, Adam J., et al. “CHARACTERISTICS OF PERSONS WITH TYPE 2 DIABETES AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE PRESCRIBED SGLT-2I AND/OR GLP-1RA AMONG CARDIOLOGY CLINICS IN THE US: INSIGHTS FROM A LARGE IMPLEMENTATION TRIAL.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 83, no. 13, 2024, pp. 1889–1889.

Nelson AJ, Pagidipati NJ, Kaltenbach L, Green J, Lopes RD, Al-Khalidi H, Aroda V, Cavender MA, Kirk J, Lingvay I, Magwire M, Pop-Busui R, Richardson CR, Webb L, Leyva M, Washington A, Pak J, Gaynor T, Granger CB. CHARACTERISTICS OF PERSONS WITH TYPE 2 DIABETES AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE PRESCRIBED SGLT-2I AND/OR GLP-1RA AMONG CARDIOLOGY CLINICS IN THE US: INSIGHTS FROM A LARGE IMPLEMENTATION TRIAL. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2024. p. 1889–1889.